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Abstract
Background
It is well established that coronary artery disease progresses along with myocardial disease.
However, data on the association between coronary artery calcium (CAC) and echocardio-
graphic variables are lacking.
Methods and results
Among 2,650 Framingham Study participants (mean age 51 yrs, 48% women; 40% with
CAC>0), we related CT-based CAC score to left ventricular (LV) mass index (LVMi), LV
ejection fraction (LVEF), E/e’, global longitudinal strain (GLS), left atrial emptying fraction
(LAEF), and aortic root diameter (AoR), using multivariable-adjusted generalized linear
models. CAC score (independent variable) was used as log-transformed continuous [ln
(CAC+1)] and as a categorical (0, 1–100, and�101) variable. Adjusting for standard risk
factors, higher CAC score was associated with higher LVMi and AoR (βLVMI per 1-SD
increase 0.012, βAoR 0.008; P<0.05, for both). Participants with 1�CAC�100 and those
with CAC�101 had higher AoR (βAoR 0.013 and 0.020, respectively, P = 0.01) than those
with CAC = 0. CAC score was not significantly associated with LVEF, E/e’, GLS or LAEF.
Age modified the association of CAC score with AoR; higher CAC scores were associated
with larger AoR more strongly in older (>58 years; βAoR0.0042;P<0.007) than in younger
(�58 years) participants (βAoR0.0027;P<0.03).
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Conclusions
We observed that subclinical atherosclerosis was associated with ventricular and aortic
remodeling. The prognostic significance of these associations warrants evaluation in addi-
tional mechanistic studies.
Introduction
Coronary artery calcium (CAC) determined by computed tomography is a marker of subclini-
cal atherosclerosis,[1] a non-invasive measure of coronary artery disease,[2] and a strong pre-
dictor of future coronary heart disease (CHD).[3] A CAC score of zero has been associated
with a very low risk of obstructive CHD,[4] and middle-aged adults with a CAC score as low
as 1–19 are shown to have higher risk of CHD events compared to those with CAC = 0 over 10
years of follow-up.[2] Morever, a high CAC score (CAC� 400) is associated with higher risk
of incident CHD and may trigger further investigations for its diagnosis and treatment,[4]
while CAC scores in the intermediate range (>100 but<300) may also justify noninvasive fol-
low-up examinations for CHD risk prediction and management.[4]
The presence and severity of CAC have been linked to poor myocardial perfusion among
individuals without overt clinical CHD.[5] In a recent meta-analysis of six studies involving
2,123 symptomatic and asymptomatic patients with suspected coronary artery disease, the
prevalence of inducible myocardial ischemia rose with a gradual increase of the CAC score.[6]
Edvardsen et al reported that regional CAC was associated with regional myocardial dys-
function, as measured by cardiac magnetic resonance imaging, among individuals without
prevalent heart disease.[7] Subclinical atherosclerosis may also lead to left ventricle (LV)
remodeling manifested by increased LV mass (LVM),[8] and worse LV diastolic function.[9]
The precise mechanisms involved in the LV remodeling and diastolic disfunction are not
clear. We could elucidate that the increase in wall thickness, a feature of greater LV mass, may
result in impaired myocardial relaxation, increased ventricular stiffness, and increased LV fill-
ing pressure[10,11] and that changes in aortic stiffness may also lead to LV remodeling. How-
ever, we cannot discard the possibility that a hypertrophied ventricle may produce damaging
pressure swings that promote CAC or that aortic stiffness may simultaneously lead to
increased CAC and LV remodeling. Changes in LV structure and function may also potentially
affect left atrial (LA) structure and function.[12] LA remodeling can be identified by increased
LA dimensions and reduced total LA emptying fraction (LAEF). Subtle changes in the myocar-
dial strain can also be observed in subclinical atherosclerosis, as detected by decreased (in neg-
ative value) global circumferential and longitudinal strain (GCS, GLS).[13] In addition of the
above physiological and structural changes, the portion of the beginning of the aorta at the aor-
tic annulus, aortic root, will go through remodeling over the lifecourse and these changes can
also precede cardiovascular diseases.[14]
There are limited reports of the relation between CAC and echocardiographic variables.
While some studies have observed an association of higher CAC with higher LVMI,8 higher E/
e’,[15] and larger left atrium,[16] other studies did not observe similar relations.[17]
The overall evidence to date suggests that coronary disease interacts and progresses along
with the incipient development of myocardial disease, even in the absence of symptoms.
Accordingly, we hypothesized that participants free of overt CHD but with higher CAC score
values have worse indices of cardiac and aortic remodeling (higher LVMi, GLS and E/e’ ratio
PLOS ONE Association of CAC with echo indices
PLOS ONE | https://doi.org/10.1371/journal.pone.0233321 May 15, 2020 2 / 13
Funding: This work was partially supported by the
National Heart, Lung and Blood Institute’s
Framingham Heart Study (Contracts N01-HC-
25195 and HHSN268201500001I) and by grants
HL076784, G028321, HL070100, HL060040,
HL080124, HL071039, HL077447, HL107385,
HL126136, 2R01HL092577, 1R01HL128914,
1P50HL120163, R01HL131532 (SC),
R01HL134168 (SC); and 2-K24-HL04334. Cecilia
Castro-Diehl was supported by the
Multidisciplinary Training Program (T32) in
Cardiovascular Epidemiology (5T32HL125232).
Gary F. Mitchell was supported by Cardiovascular
Engineering., Inc; this funder provided support in
the form of salary for Gary F. Mitchell, but did not
have any additional role in the study design, data
collection and analysis, decision to publish, or
preparation of the manuscript. The specific role of
this author is articulated in the ‘author
contributions’ section.
Competing interests: Susan Cheng has received
consulting fees from Zogenix for work unrelated to
this manuscript. Gary F. Mitchell has the following
disclosures: a) grants: NIH, Novartis (both
significant); b) consulting: Novartis, Servier (both
significant); and c) ownership: Cardiovascular
Engineering, Inc. (significant). These affiliations do
not alter our adherence to PLOS ONE policies on
sharing data and materials.
and lower LVEF, LAEF, and aortic root diameter [AoR]) than participants with lower values
of CAC score.
Methods
Study sample
Details of the design of the Offspring and the Third Generation cohorts of the Framingham
Heart Study have been reported previously.[18] Participants in the Offspring cohort under-
went routine transthoracic echocardiography during the eighth examination cycle (2005–
2008) and computerized tomography scanning of their coronary arteries at the end of the
eight examination cycle (2008–2011). Participants in the Third-Generation cohort underwent
tomography scanning and transthoracic echocardiography during their first examination
cycle (2002–2005). For the Offspring cohort, covariates and echocardiographic variables were
measured approximately 3 years before the assessment of CAC (covariates and echocardio-
graphic variables were assessed between 2005–2008 whereas CAC was assessed between 2008–
2011). For the Third generation cohort, all variables (CAC, covariates, and echocardiographic
variables) were assessed contemporaneously.
For the present investigation, there were 3528 eligible participants (S1 Fig). We excluded
participants if they had prevalent myocardial infarction and/or congestive heart failure
(n = 57), were not in sinus rhythm (n = 129), or had incomplete data on echocardiographic
indices (n = 692), resulting in a final sample size of 2650 participants with available CAC mea-
surements and data on echo indices of interest for the present investigation. Following stan-
dardized protocols, participants provided a detailed medical history and underwent physical
examination and laboratory tests for cardiovascular disease risk assessment. The study was
approved by the Institutional Review Board of Boston University Medical Center, and all par-
ticipants gave written informed consent.
Coronary Artery Calcium (CAC) assessment
CAC was assessed by chest CT using an eight-slice multidetector CT scanner (LightSpeed
Ultra; General Electric Milwaukee, WI). All participants were scanned twice according to a
sequential scan protocol described previously.[19] Experienced readers examined indepen-
dently the scans offline to identify and quantify coronary calcification, as reported previously.
[19,20] The amount of CAC was calculated using the Agatston score, [20,21] and the scores
from two scans were averaged. We reported excellent reproducibility in the FHS cohorts.[20]
Echocardiographic measurements
Transthoracic echocardiography with color flow and tissue Doppler imaging was performed
by experienced sonographers on all attendees using a Hewlett-Packard Sonos 5500 Ultrasound
machine (Phillips Healthcare, Andover, MA) and analyzed using an offline system (DigiView
System Software (ver. 3.7.9.3, Digisonics Inc., Houston, Texas, USA)). Linear cardiac dimen-
sions, and annular displacement and velocities were measured. Echocardiographic images
were digitized and stored in Digital Imaging and Communications in Medicine (DICOM) for-
mat. Speckle tracking echocardiographic strain analysis of the LV based on 2D images was also
performed using an offline image analysis program (2D Cardiac Performance Analysis v1.1,
TomTec Imaging Systems, Unterschleissheim, Germany). We categorized the echocardio-
graphic indices as primary (standard echocardiographic indices for which there are published
associations with several outcomes) and secondary (additional novel echocardiographic
indices).
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Two independent readers evaluated all echocardiographic measurements to determine
agreement. The reproducibility of the echocardiographic measurements was excellent.[22] A
validated test was performed for assessing intra- and inter-reader variability. Correlation
within readers (for first two readings) was 0.917 to 0.983, and between readers (for first read-
ing) was 0.901 to 0.967. FHS has reported no major systematic bias across exams due to change
of equipment.[23]
Primary echocardiographic indices
For the present investigation, we used the following primary echocardiographic indices: left
ventricular (LV) mass indexed by body surface area (LVMi), LV ejection fraction (LVEF), aor-
tic root diameter (AoR), left atrial emptying fraction (LAEF), E/e’, and global longitudinal
strain (GLS).
LV mass (LVM) was derived from measurements of end-diastolic LV septal wall thickness
(SWT), posterior wall thickness (PWT), LV end-diastolic diameter (LVDD) and LV end-sys-
tolic diameter (LVSD)[24] using the American Society of Echocardiography (ASE)-recom-
mended formula,[25] and then indexed to body surface area. LVEF was calculated from the
LV volumes, LV end-diastolic (LVEDV) and LV end-systolic volume (LVESV), derived from
linear measurements as previously described.[26] AoR was measured using the leading-edge
technique as previously described.[27] LAEF, an indicator of LA total emptying, was calculated
based on minimum (min) and maximum (max) LA volumes obtained at mitral valve closure
(systole) and just before mitral valve opening (after LA contraction), respectively, using the fol-
lowing formula ([LAmax—LAmin]/LAmax)�100.[28,29] LAmax and LAmin were obtained
using the recommended Simpson’s biplane summation of disks.[30] LAmax and LAmin were
calculated by averaging LAmax and LAmin measurements from the apical two- and four
chamber views.[31] We included LAEF only for the Offspring cohort (n = 885 participants), in
this analysis, because LAEF data were not available for participants in the Third Generation
cohort. Early transmitral Doppler flow velocity (E wave) and tissue Doppler assessment of
peak early diastolic tissue velocity of the lateral mitral annulus (e’) were measured by pulse-
wave Doppler from the apical four-chamber view.[32] The ratio of E/e’ was used as a surrogate
for LV filling pressure. Global longitudinal strain (GLS) represents the myocardial shortening
in the long axis plane and was obtained using apical views. In the present investigation, GLS
was calculated as the average peak longitudinal strain measured in 12 regions in the apical
two- and four chamber views.[33] Since GLS values are negative, a value less than −20% is
likely considered to be normal[13] whereas GLS values closer to zero indicate worse cardiac
function.
Secondary echocardiographic indices
The following secondary echocardiographic indices were also analyzed: LVDD, LV wall thick-
ness (LVWT), LV wall motion (LVWM) abnormality, mitral annular plane systolic excursion
(MAPSE), global circumferential strain (GCS), and LV longitudinal segment synchrony (LSS).
LVWM is an indicator of global LV function. MAPSE is an indicator of long axis LV func-
tion and was obtained by measuring the mitral annular displacement.[34] GCS is a measure of
global deformation and represents the myocardial shortening in the short axis.[13] LSS was
calculated as the standard deviation (SD) of time-to-peak systolic longitudinal strains[35] gen-
erated from speckle-tracking echocardiography.
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Covariates
For the present investigation, we used the following covariates: age, sex, cigarette smoking
(yes/no) assessed by questionnaire, body mass index, systolic and diastolic blood pressure
(measured by a study physician using a standardized protocol), self-reported use of blood pres-
sure-lowering medications, diabetes status (defined as fasting glucose�126 mg/dL or treat-
ment with either insulin or a hypoglycemic agent), the ratio of serum total cholesterol over
high density-lipoprotein, use of lipid-lowering medication, and physical activity.
Each FHS clinic examination included anthropometry, blood pressure measurements, and
electrocardiography. All procedures followed a standardized protocol. Height and weight were
measured during the examination and body mass index (BMI) was calculated as weight in
kilograms divided by height in meters squared (kg/m2). Heart rate was derived from electro-
cardiography. Participants also underwent phlebotomy after overnight fast for measurement
of glucose, lipids and creatinine. After blood specimens were collected, the plasma was sepa-
rated. HDL was separated by precipitating the other lipoproteins with heparin-manganese
chloride using a modification of the technique described by Burstein et al.[36] Cholesterol
concentrations were determined by the Abell-Kendall method. Triglycerides were determined
by a modification of the Keesler-Lederer method.[37] Glucose was measured in whole blood
and was determined using the method of Somogyi-Nelson.[38]
We estimated the physical activity index using self-reported hours of sleep, sedentary, light,
moderate and vigorous activity from the FHS clinic examination. The physical activity index
was calculated using the following equation: [sleep time + (1.1�sedentary time) + (1.5�slight
activity) + (2.4�moderate activity) + (5�heavy activity)].
Statistical analysis
We natural logarithmically-transformed values of LVMi, LVEF, AoR and E/e’ to normalize
their skewed distributions. Because CAC scores also showed a skewed distribution, and many
participants had a CAC score of zero, we added 1 to all CAC values and then logarithmically-
transformed the new values [ln(CAC+1)].
We used generalized linear models to relate CAC score (independent variable) to echocar-
diographic indices (dependent variables; separate model for each), adjusting for age, sex, BMI,
smoking (yes/no), systolic and diastolic blood pressure, current use of hypertensive medica-
tions (yes/no), diabetes (yes/no), total cholesterol/HDL ratio, use of lipid-lowering medication,
and physical activity, and accounted for relatedness among individuals. We also accounted for
multiple comparisons by using false discovery rates, with a q value<0.05 indicating statistical
signficance.[39] We also created restricted cubic splines to assess the linearity of the associa-
tion between the echocardiographic variables and CAC.
We first examined CAC score as a continuous variable, and then as a categorical variable
(0, 1–100 and�101; cutpoints published in the literature) with CAC = 0 serving as the refer-
ence category.[40] We also tested for effect modification by age and sex by including corre-
sponding interaction terms in the models. A P-value of<0.05 for the interaction was
considered statistically significant.
Results
Characteristics of the study sample are shown in Table 1. Our sample included young, middle-
aged and older adults (48% women) with a BMI in the overweight range. The prevalence of
CAC>0 was 40% in our sample. More men than women had CAC>0 (49% vs 29%) and CAC
�101 (20% vs 9%). Participants’ characteristics by absence vs. presence of CAC are shown in
PLOS ONE Association of CAC with echo indices
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Table 1. Characteristics of study sample.
Men (n = 1369) Women (n = 1281)
Clinical Characteristics
Age, y 50±12 53±11
Height, cm 177±7 163±6
Weight, kg 87±14 71±16
Body mass index, kg/m2 27.9±4.1 26.7±5.7
Smoking, % 10 12
Systolic blood pressure, mm Hg 123±14 120±16
Diastolic blood pressure, mm Hg 78±9 73±9
Hypertension, % 31 29
Hypertension treatment, % 20 22
Heart rate, bpm 58±9 61±9
Diabetes, % 6 4
Serum creatinine, mg/100ml 0.9±0.2 0.7±0.2
Total cholesterol, mg/dL 191±34 194±35
HDL cholesterol, mg/100ml 48±13 63±18
LDL cholesterol, mg/100ml 118±31 110±31
Triglycerides, mg/100ml 106(73–156) 88(65–126)
Lipid-lowering medication use, % 21 16
Phyical activity index 38±8 36±6
Coronary artery calcification (CAC)
Coronary Artery Calcium Score 0 (0–56) 0 (0–3)
Prevalence of CAC Score, %
0 51 71
1–100 29 20
�101 20 9
Echocardiographic variables
Primary
LV Mass Index, g/m2 91 (81,102) 75 (67,85)
LV Ejection Fraction, % 65 (62,68) 67 (64,71)
Aortic Root, cm 3.4 (3.2,3.6) 3.0 (2.8,3.2)
LA Emptying Fraction, % 48.3 (46.7,49.6) 48.3 (46.3,9.9)
E/e’ratio 5.7 (4.9,6.7) 6.4 (5.4,7.7)
GLS, % -19.0 (-20.8,-17.3) -21.2 (-23.1,-19.3)
Secondary
LV Diastolic Diameter, cm 5.2 (4.9,5.4) 4.7 (4.5,5.0)
LV Wall thickness, cm 2.0 (1.9,2.1) 1.7 (1.6,1.8)
Wall motion abnormality, % 2.0 0.9
MAPSE, cm 1.6 (1.4,1.7) 1.6 (1.4,1.7)
GCS, % -28.9 (-31.8,-25.8) -30.7 (-34.2,-27.5)
LSS, msec 99 (75,117) 96 (59,116)
All values shown are mean ± standard deviation or median (Q1,Q3), unless otherwise specified
LAEF is computed among Offspring participants only
LV = Left Ventricular, LA = Left Atrial GLS = Global longitudinal strain, MAPSE = Mitral Annular Plane Systolic
Excursion, GCS, Global circumferential strain, LSS, Longitudinal segmental synchrony
https://doi.org/10.1371/journal.pone.0233321.t001
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S1 Table. Participant characteristics by cohort (Offspring vs. Third Generation) are shown in
S2 Table.
Adjusting for covariates, higher CAC values were associated with higher levels of LVMi and
AoR. We did not observe an association between continuous CAC and LVEF, LAEF, E/e’ or
GLS (Table 2). Participants with CAC score of 1–100 and those with CAC score�101 had
higher AoR values compared to the referent group with CAC score of zero. We did not observe
an association between coronary artery calcium and any of the secondary echocardiography
variables selected (data not shown).
Fig 1 shows multivariable-adjusted least square mean (LSM) values for LVMi, AoR, LAEF,
and E/e’ according to CAC score category.
Additionally, we observed effect modification by age, but not by sex, for the association of
CAC score with AoR (P for interaction = 0.049). In stratified analysis, the association of CAC
values varied with age, with the association being stronger among older participants (age >58
yrs) than in younger participants. Fig 2 shows multivariable-adjusted LSM values for AoR by
CAC score category, stratified by median age.
When testing for non-linearity of associations using multivariable-adjusted restricted cubic
splines relating the log-transformed CAC to the primary echocardiographic measures, LVMi
and AoR showed linear associations with log-transformed CAC (S2 Fig).
Discussion
Principal findings
In our large community-based sample of middle-aged and older participants without conges-
tive heart failure or myocardial infarction, we observed that higher CAC scores were associated
with higher values of LVMi and AoR consistent with potential adverse effects of subclinical
atherosclerosis on myocardial, chamber, and aortic remodeling. Of note, the effect sizes were
modest and their clinical significance, if any, is unknown.
Table 2. Associations between CAC and echocardiographic indices.
LVMi (log(g/m2)) LVEF (log(%)) AoR (log(cm)) LAEF§ (%) E/e0 (log(E/e0 ratio)) GLS (%)
CAC score Estimate
(SE)
P-
value
Estimate
(SE)
P-
value
Estimate
(SE)
P-value Estimate
(SE)
P-
value
Estimate
(SE)
P-
value
Estimate
(SE)
P-
value
CAC as continuous variable
CAC� 0.012
(0.004)
0.048 −0.002
(0.002)
0.54 0.008
(0.002)
0.005 −0.220
(0.092)
0.06 0.009
(0.006)
0.24 0.049
(0.069)
0.61
CAC as categorical variable
CAC = 0 (n = 1602) Referent Referent Referent Referent Referent Referent
CAC = 1–100†
(n = 659)
0.014
(0.008)
0.20 0.004 (0.004) 0.55 0.013
(0.004)
0.01 -0.090
(0.190)
0.69 0.001
(0.011)
0.94 0.098
(0.140)
0.61
CAC� 101†
(n = 389)
0.020
(0.012)
0.23 −0.006
(0.006)
0.44 0.020
(0.006)
0.01 −0.654
(0.265)
0.06 0.031
(0.016)
0.14 0.079
(0.193)
0.71
P-trend‡ 0.048 0.59 <0.001 0.02 0.11 0.57
� Estimates are per 1-SD increase in ln(CAC+1)
† reference group, CAC = 0 (n = 1602)
‡ trends across the CAC categories.
§ LAEF estimate among Offspring participants only.
All models were adjusted for age, sex, smoking (yes/no), systolic blood pressure, diastolic blood pressure, current use of hypertensive medications (yes/no), diabetes
(yes/no), total cholesterol/HDL ratio, lipid-lowering medication, physical activity index, and body mass index. P-values are FDR q-values.
https://doi.org/10.1371/journal.pone.0233321.t002
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CAC score and LV structure and function. The positive association between CAC and
LVMi is consistent with previous studies. For example, Gardin et al reported that a 5-year
increase in LVM is associated with higher odds of CAC.8 However, both CAC and echocardio-
graphic variables were measured 10 years apart, rendering the directionality of this association
unclear. Other investigations reporting a direct association between CAC scores and LVMi
have used smaller sample sizes and included elderly participants or participants with suspected
coronary artery disease, who are at much higher risk of both CAC and LV hypertrophy.[15,
41] In a most recent investigation from the CARDIA study, with 5115 white and black partici-
pants who were healthy at baseline, higher CAC scores among middle-aged people were asso-
ciated with higher LV mass adjusting for standard cardiovascular risk factors.[9] The exact
mechanisms involved in the association between CAC score and LVMi are not known.
In our sample, we did not observe an association of CAC with E/e’. However, in a study by
Osawa et al,[15] participants with CAC�400 had significantly higher E/e’ than those with
CAC = 0–9, 10–99, or 100–399. However, the participants were older (70±8 years) than in our
sample (52±12 years), and the mean E/e’was higher (12±6) than that in our sample (median E/
e’ = 5.7 [4.9–6.7] for men and 6.4 [5.4–7.7] for women). In our investigation, participants did
not have CAC values close to 400, contrary to the aforementioned study[15]. Furthermore,
other investigations have reported higher CAC scores being associated with higher LV filling
pressures among healthy participants[9] as well as among those with suspected coronary artery
disease.[42] However, in a retrospective study of 349 asymptomatic patients with a median
CAC score of 14 (Q1, Q3: 0, 136), no association between CAC score and diastolic dysfunction
was observed,[17] but, in this group of participants, higher CAC score was associated with
higher LA volume index, a surrogate of diastolic dysfunction.
CAC score and aortic remodeling. We observed a positive association between CAC and
aortic root diameter (AoR) values and the association was stronger among older (compared to
younger) participants. Subclinical atherosclerosis as assessed by CAC may be associated with
enlargement of the AoR. It is conceivable that CAC parallels aortic atherosclerosis, and the lat-
ter is associated with compensatory enlargement of the root as a result of atherosclerotic bur-
den (Glagov phenomenon[43]). Although there are a few studies that have observed an
association between CAC and aortic root calcification using CT,[44] to the best of our knowl-
edge, studies investigating the relation between CAC and AoR measured by echocardiography
are lacking. Medial artery calcification is associated with advanced age and this type of calcifi-
cation is linked to arterial stiffness;[14] this may explain why we observed a stronger associa-
tion between CAC and AoR among older participants (those with a median age>58).
We did not observe an association between CAC and LVEF, LAEF, E/e’ or GLS, indicators
of systolic and diastolic chamber and myocardial function, perhaps because the prevalence of
CAC in our sample was relatively low. We did not observe significant associations between
CAC and some of the echocardiographic variables perhaps due to the fact that our sample had
a very low prevalence of CAC >300.
Strengths and limitations. Our study sample had a wide age range, with a high percent
being hypertensive. We conducted a comprehensive assessment of cardiovascular risk factors
and several indicators of cardiac remodeling to detect associations between CAC burden and
cardiac and aortic remodeling. Previous investigations have evaluated only a limited number
of echocardiographic variables.
However, our study has several limitations. First, we cannot infer causality of any of the
observed associations, given the cross-sectional nature of design. Second, because the study
participants were predominantly white, largely middle-class, and middle-aged (median age 58
years), our findings cannot be generalized to other age groups or ethnicities; additional studies
of multiethnic samples are warranted. Third, CAC values are highly correlated with
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Fig 1. Least square means of echocardiographic indices by CAC category. Least-Square Means were adjusted for age, sex, smoking, systolic blood pressure, current
use of hypertensive medications, diabetes, total cholesterol/HDL ratio, lipid-lowering medication and physical activity index. �Comparison versus CAC = 0, p<0.05
��Comparison versus CAC = 1–100, p<0.05.
https://doi.org/10.1371/journal.pone.0233321.g001
Fig 2. Associations of CAC with AoR stratified by median age. Least-Square Means were adjusted for age, sex, smoking, systolic blood pressure, diabetes, total
cholesterol/HDL ratio, current use of hypertensive medication, lipid-lowering medication and physical activity index. �Comparison versus CAC = 0, p<0.05
��Comparison versus CAC = 1–100, p<0.05.
https://doi.org/10.1371/journal.pone.0233321.g002
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atherosclerotic plaque area,[1] but not all atherosclerotic plaques contain calcium. Therefore,
the predominantly low coronary calcium levels in our sample may have limited our statistical
power to detect associations of atherosclerotic plaques and cardiac remodeling. Fourth, some
of the observed associations may be statistically significant but given the small magnitude of
effect sizes, we understand that they may not have a high clinical importance. Fifth, the Third
generation participants did not have measurements on LAEF, so the sample size was smaller
for that part of the analysis. Finally, the magnitude of the effect sizes are small and we cannot
rule out measurement error.
Conclusion
Our results provide suggestive evidence of an association between subclinical atherosclerosis
and cardiac and aortic remodeling in individuals free of congestive heart failure and myocar-
dial infarction. These findings indicate that interactive as well as parallel development of coro-
nary vascular and myocardial disease may be a common phenomenon among aging
individuals in our community-based sample. Additional mechanistic studies are warranted to
further clarify the pathophysiological basis of the observed associations and the prognostic sig-
nificance for the use of CAC on cardiac and aortic remodeling, if any, in more diverse
populations.
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